Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib plus Pembrolizumab in Advanced Urothelial Carcinoma
NCT03534804Phase 2Completed
- Sponsor
- University of Utah
- Start
- Sep 2018
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in urothelial carcinoma (UC), sponsored by University of Utah. Started Sep 2018; status: completed.
02
Drugs
cabozantinib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT03534804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534804.